GlassScriptPhysician profile
Bernard Scott Davis
NPI 1043559214
$532.88
in general payments reported to CMS, 2019-2025
10 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $27.79 · 2023: $16.95 · 2024: $269 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $147.12 | 2024 | Restoration, Insignia, Mako |
| Depuy Synthes Sales INC. | $122.25 | 2024 | Vivigen Mis Delivery System, Fibergraft Aeridyan Matrix |
| Mvp Orthopedics INC | $114.45 | 2021 | |
| Indivior INC. | $41.72 | 2025 | Sublocade |
| Axsome Therapeutics, INC. | $25.29 | 2025 | Symbravo |
| Collegium Pharmaceutical, INC. | $21.08 | 2025 | Xtampza |
| Csl Behring | $16.95 | 2023 | Kcentra |
| Bioventus LLC | $16.23 | 2025 | Xcell |
| Abbvie INC. | $14.90 | 2022 | |
| Intuitive Surgical, INC. | $12.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.